An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration.
Fung AE, Lalwani GA, Rosenfeld PJ, Dubovy SR, Michels S, Feuer WJ, Puliafito CA, Davis JL, Flynn HW Jr, Esquiabro M.
Am J Ophthalmol. 2007 Apr;143(4):566-83.PMID: 17386270 [PubMed - indexed for MEDLINE]Related articles